MIRA Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
MIRA Pharmaceuticals, Inc. (MIRA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $5.35 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-28
- MIRA Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was $1.83M.
- MIRA Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $0.00.
- MIRA Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $3.52M.
- MIRA Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $5.35M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.83M derived: sum of 2 quarters · filed 2025-03-28 | $5.35M derived: sum of 3 quarters · filed 2025-03-28 | $5.35M 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-12 | $3.52M derived: sum of 2 quarters · filed 2024-11-12 | $3.52M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.52M 10-Q/A · filed 2024-08-16 | $3.52M 10-Q/A · filed 2024-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |